What is the current price / NAV of Aditya Birla SL Pharma & Healthcare Fund?
The current NAV of Aditya Birla SL Pharma & Healthcare Fund is ₹29.90, as of 20th June 2025.What are the returns of Aditya Birla SL Pharma & Healthcare Fund?
The Aditya Birla SL Pharma & Healthcare Fund was launched on 10th July 2019. This mutual fund's past returns are as follows:- 1 Year Returns: 9.97%
- 3 Year Returns: 23.33%
- 5 Year Returns: 18.85%
What are the top 5 sectoral holdings of Aditya Birla SL Pharma & Healthcare Fund?
The top sectors Aditya Birla SL Pharma & Healthcare Fund has invested in are as follows:- Pharmaceuticals | 76.75%
- Labs & Life Sciences Services | 18.71%
- Investment Banking & Brokerage | 2.17%
- Others | 1.49%
- Diversified Chemicals | 0.88%
What are the top 5 holdings of Aditya Birla SL Pharma & Healthcare Fund?
The top 5 holdings for Aditya Birla SL Pharma & Healthcare Fund are as follows:- Sun Pharmaceutical Industries Ltd | 12.08%
- Cipla Ltd | 7.69%
- Apollo Hospitals Enterprise Ltd | 7.18%
- Abbott India Ltd | 6.09%
- Torrent Pharmaceuticals Ltd | 5.47%
What is the asset allocation of Aditya Birla SL Pharma & Healthcare Fund?
The asset allocation for Aditya Birla SL Pharma & Healthcare Fund is as follows:- Equity | 97.94%
- Cash & Equivalents | 2.06%
What is the AUM of Aditya Birla SL Pharma & Healthcare Fund?
The AUM (i.e. assets under management) of Aditya Birla SL Pharma & Healthcare Fund is ₹814.18 Cr as of 20th June 2025.What is the expense ratio of Aditya Birla SL Pharma & Healthcare Fund?
The expense ratio of Aditya Birla SL Pharma & Healthcare Fund Plan is 2.33 as of 20th June 2025.What is the alpha ratio of Aditya Birla SL Pharma & Healthcare Fund?
The alpha ratio for the Aditya Birla SL Pharma & Healthcare Fund is -2.06
Alpha is the excess return of a fund compared to its expected return, based on its beta and the risk-free rate. Positive alpha indicates that the fund has outperformed its expected return, while negative alpha suggests underperformance.
What is the volatility or standard deviation of Aditya Birla SL Pharma & Healthcare Fund?
The volatility or standard deviation for the Aditya Birla SL Pharma & Healthcare Fund is 14.47
Standard deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.
What is the sharpe ratio of Aditya Birla SL Pharma & Healthcare Fund?
The Sharpe ratio for the Aditya Birla SL Pharma & Healthcare Fund is 0.47
The Sharpe ratio is a measure of risk-adjusted return that evaluates the performance of a mutual fund, by adjusting for its risk. Higher Sharpe ratio indicates a better risk-adjusted performance. A positive Sharpe ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe ratio suggests that the MF did not adequately compensate for the risk.
What is the Sortino ratio of Aditya Birla SL Pharma & Healthcare Fund?
The Sortino Ratio for the Aditya Birla SL Pharma & Healthcare Fund is 0.05
The Sortino ratio of a mutual fund is a measure of its risk-adjusted return, considering only downside volatility. It helps investors evaluate how well a fund is performing relative to its downside risk. A higher Sortino ratio (value >1) means the fund generates better returns for the downside risk taken.
What is the Price to Earnings (PE) ratio of Aditya Birla SL Pharma & Healthcare Fund?
The PE ratio of Aditya Birla SL Pharma & Healthcare Fund is 45.44, while category PE ratio is 53.39.
Gains are treated as short-term capital gains and taxed at 20%
Gains are treated as long-term capital gains and taxed at 12.5%